These results suggested that NFKB1 mutation (G430E) promotes the survival of cervical cancer cells following irradiation, which was consistent with the result that mutation rates of this mutation are significantly elevated in cells after radiotherapy. The gene discussed is NFKB1; the disease is cervical cancer.